Hussman Strategic Advisors, Inc. has filed a Form 13F-HR report disclosing its equity holdings as of September 30, 2026. The filing lists 263 individual securities held by the firm, managed by President John P. Hussman.
The report details the firm's portfolio across various sectors, including healthcare, technology, and consumer goods. Notable positions include large holdings in companies such as AnaptysBio Inc., ArdeLyx Inc., AstraZeneca (listed as AstraZeneca Pharmaceuticals International plc), and Arvinas Inc. The firm also holds significant stakes in financial services, with positions in Citigroup Inc. and BankUnited Inc.
The filing provides specific share counts for each disclosed position, reflecting the firm's equity exposure as of the report date.
